Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance studyResearch in context

Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance studyResearch in context

Summary: Background: Studies have shown that some antineoplastic agents may be associated with interstitial lung disease (ILD), but large-scale real-world data are lacking. This study aimed to detect signals of disproportionate reporting for ILD associated with novel antineoplastic agents used in b...

Full description

Saved in:
Bibliographic Details
Main Authors: Zijun Zhu, Yongxin Li, Chaoyong Zhu, Qiuxia Dong, Yixiao Zhang, Zhilin Liu, Dengfeng Ren, Fuxing Zhao, Jiuda Zhao
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:EClinicalMedicine
Subjects:
Adverse event
Breast cancer
Interstitial lung disease
Novel antineoplastic agent
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537025000926
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items